打破沉默:儿童药物开发中的挑战和机遇
Kanwaljit Singh1, Tim Franson2, Susan McCune3
1The Critical Path Institute, Tucson, AZ, USA.
Pediatric research
|February 8, 2025
概括
由于监管障碍和经济问题,儿童药物开发资金不足. 解决方案包括新技术,创新试验,现实数据,以及改善儿童健康的公私合作伙伴关系.
科学领域:
- 儿科药理学 儿科药理学
- 药物开发 药物开发
- 监管科学 监管科学
背景情况:
- 由于独特的生理需求和试验复杂性,儿童在药物开发中缺乏服务.
- 有限的儿科疗法缺乏受控试验的证据,许多用于非标签.
- 制药公司正在降低儿科研究的优先级,专注于更有利可图的成人市场.
研究的目的:
- 讨论儿科药物开发中资金不足和优先考虑不足的根本原因.
- 探索改善儿科药物管道的潜在解决方案.
- 强调在儿科治疗中需要创新和投资.
主要方法:
- 审查儿科药物开发的挑战,包括道德和监管方面的问题.
- 确定经济阻碍因素和缺乏强有力的宣传作为关键原因.
- 探索新兴技术 (人工智能,建模,模拟),创新的试验设计,现实数据和公私合作伙伴关系作为解决方案.
主要成果:
- 儿科药物开发仍然存在重大挑战,包括资金不足和复杂的监管框架.
- 关键的障碍包括缺乏宣传,监管障碍和经济阻碍.
- 新兴技术,创新的试验设计,现实数据和公私合作伙伴关系被认为是关键的解决方案.
结论:
- 解决儿科药物开发的资金不足和优先级不足需要采取多方面的方法.
- 加强监管激励措施,促进行业承诺和参与患者倡导对于可持续的管道至关重要.
- 通过创新优先考虑儿科健康是改善儿童结果的道德要求.
更多相关视频
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
2.5K
10:15Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
Published on: March 22, 2017
6.9K
相关概念视频
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Prescription, Nonprescription and Orphan Drugs
682
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
682
Drug Administration and Therapy Phases: Overview
405
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
405
